Wei Hu

4PUBLICATIONS
34CO-AUTHORS
Molecular targetsPredictive and prognostic markersInnate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 07, 2022
Natural high-avidity T-cell receptor efficiently mediates regression of cancer/testis antigen 83 positive common solid cancers.

Qingyang Li, Wei Hu, Baoyi Liao

|Apr 27, 2022
Combination Neoantigen-Based Dendritic Cell Vaccination and Adoptive T-Cell Transfer Induces Antitumor Responses Against Recurrence of Hepatocellular Carcinoma.

Sui Peng, Shuling Chen, Wei Hu

|Oct 26, 2021
Specific CD8+ TCR Repertoire Recognizing Conserved Antigens of SARS-CoV-2 in Unexposed Population: A Prerequisite for Broad-Spectrum CD8+ T Cell Immunity.

Wei Hu, Meifang He, Xiaoning Wang

|Feb 28, 2020
HLA class I restricted epitopes prediction of common tumor antigens in white and East Asian populations: Implication on antigen selection for cancer vaccine design.

Wei Hu, Meifang He, Liangping Li

Pageof 1

Frequent Collaborators

1 joint publications

Qiang Sun

1 joint publications

Sui Peng

1 joint publications

Shuling Chen

1 joint publications

Jie Mei